Gathering high-end talents, the first postdoctoral report meeting of Biosis Healing successfully held

by

On July 9, Beijing Biosis Healing Biological  Technology Co., Ltd. held the first postdoctoral report meeting. The Professor Chen Jie from Beijing Chao-Yang Hospital, Capital Medical University, Professor Chen Dafu from Beijing Institute of Orthopedic Trauma, and Professor Zhang Guifeng from Institute of Process Engineering, Chinese Academy of Sciences were invited to form an expert review team of the meeting. Professor Zhao Bo,  postdoctoral supervisor and the founder of Biosis Healing, vice president of human resources Lun Xinyi , and related staff of the R&D department and quality department attended the report. The meeting was presided over by vice president Lun Xinyi.

Taking innovation and research and development as the foundation of the enterprise, it is imperative to build a postdoctoral research station

Biosis Healing postdoctoral research station was established in December 2018 and has successively introduced 6 postdoctoral talents. The three review experts are all witnesses to the establishment of the postdoctoral research stationof Biosis Healing. and they are also top experts in the postdoctors’ research field. They have given us a lot of advice and help at many major turning points in Biosis Healing’s development. For all the postdoctors and the company, it is a rare learning opportunity to receive the experts’ guidance.

For Professor Zhao Bo, the founder and postdoctoral supervisor of Biosis Healing, who attaches great importance to scientific research and talent training, it is important to establish a Postdoctoral Research Station. Since its establishment in 2012, Biosis Healing has insisted on "innovation, research and development" as the foundation of the company. Because Zhao Bo knows that the cultivation of high-tech talents is the reservoir for the development of enterprises. It is necessary to improve the innovative scientific research mechanism and management system, make full use of the postdoctoral innovation platform, and accelerate the introduction, training, and bringing up young scientific and technological reserve talents with core competitiveness. It is very important to the development of Biosis Healing and the development of the entire medical industry, the postdoctoral research station has also handed in a satisfactory answer in the past three years since its establishment.


The core products go on sale and enter "new blue ocean", and the achievement of the postdoctoral research station are "exceptional"

In the past three years, the postdoctoral research station has implemented a number of basic research and clinical application research around Biosis Healing SIS biomaterials with independent intellectual property rights, and has achieved fruitful results.

In 2018, the first product of SIS material inguinal hernia graft went on sale. With its excellent product quality, it quickly entered hundreds of hospitals across the country. In 2021, it obtained the EU CE certificate for the only animal-derived graft product in China, and realized its clinical application in Europe.

In 2019, Anal Fistula Plug, the second product of SIS material, was put on the market. It is the first domestic fistula plug product of SIS material, filling the domestic gap. Make the treatment of anal fistula disease from destructive incision treatment to minimally invasive protective repair treatment, opening a new era of anal fistula protective repair.

In 2020, in the face of the national shortage of epidemic prevention materials caused by the sudden new crown pneumonia epidemic, Biosis Healing will urgently switch to the production of epidemic prevention materials. The postdoctoral research station undertook the important task of development and transformation of epidemic prevention materials. It took one month to complete the development and industrialization of medical masks and medical protective clothing product series. Independently developed a reusable KN95 protective mask that met Chinese standards and put it into production, which solved the problem of mass production of masks caused by the shortage of meltblown cloth.

In 2021, Dura Repair Mesh, the third product of SIS material, goes on sale. This is also the first non-crosslinked extracellular matrix source dura product in China, which once again fills the domestic gap.

And the SIS material Oral Repair Film and Anastomotic Reinforcement Patch, which will obtained certificates, will also become the main products of SIS material in the potential market. Once on sale, it will break the dilemma of foreign monopoly.

Since the establishment of the postdoctoral research station, it has repeatedly received the “General Funding of the China Postdoctoral Science Foundation” and the “Postdoctoral International Exchange Program Academic Exchange Project Funding”, and its research results have been successively included in the top international journals in the field of materials Advanced Functional Materials (impact factor 16.8), and included in many SCI core journals such as Regenerative Biomaterials (impact factor 4.8). Since 2018, research results have obtained dozens of domestic and foreign patents, 14 products have obtained the EU CE registration certificate, 3 products have obtained domestic Class III medical device registration certificates, and 2 products have obtained domestic Class II medical device registration certificates. Postdoctoral research station results are "extraordinary".

Absorbable tissue glue and SIS promote cell proliferation molecular mechanism research, leading the world's "Chinese Biotechnology"

In addition, postdoctoral research station in the field of absorbable medical tissue glue, SIS biomaterials in the field of oral and skin repair, and research in the field of molecular mechanisms that promote cell proliferation, and other cutting-edge research in the world. Breakthrough progress has also been made.
After listening to the reports, the three experts greatly appreciated the research topics of the three postdoctors. They believed that the research content of Biosis Healing postdoctoral research station is leading and breakthrough in the field of global SIS biomaterials. Subsequently, the three review expert asked, questioned and discussed their defense reports respectively, provide relevant professional suggestions for the research content, methods and ideas of the subject, effectively communicated the difficulties and points that may be encountered in the subject, and gave many suggestions in the follow-up research direction, product transformation, etc. Finally, after a comprehensive review by the expert group, 3 postdoctoral fellows passed the reply and postdoctoral outbound smoothly.
Professor Zhao Bo said: In the future, Biosis Healing will continue to build and operate the national postdoctoral research station, a platform for the introduction and retention of outstanding high-level talents, give full play to the advantages of the postdoctoral system in scientific and technological research and talent flow, and cultivate high-level complex talents, continuous breakthrough and innovation for the company, seize the core technology highland to provide strong power, attract more high-tech talents to develop in Biosis Healing, and build the company's high-tech innovation engine.


Biosis Healing company introduction and talent strategy

Beijing Biosis Healing Biological Technology Co.,Ltd. was established in 2012, committed to providing advanced and comprehensive solutions for surgery and repair, and promoting surgical clinical innovation. Enterprises insist on technological innovation as their core competitiveness, and high-tech talents are the driving force for technological innovation and development. At the beginning of its establishment, the company spared no effort to focus on the construction of the R&D team, and introduced youth elites in the disciplines of surgery, materials science, molecular biology, new drug research and development, and formed basic research, technology development, clinical registration, system quality, intellectual property rights, etc. The layout of the department can independently implement new product laboratory research and development, pre-clinical research, clinical research, registration, system certification, pilot-scale production and other comprehensive innovative biological materials and medical device development. The company actively cultivates youth elites, cultivates the ability to independently create, design and implement projects, encourages R&D personnel to go abroad for further studies, and introduces overseas talents. The company also actively develops industry-university-research cooperation with universities, scientific research institutions, clinical hospitals, etc., and has been awarded "National High-tech Enterprise", "Postdoctoral Scientific Research research station", "Beijing-level Enterprise Technology R&D Institution", "Zhongguancun High-tech Enterprise", etc. Honorary title.

The company undertook the "Yaogu No. 1" biomedical public service platform project of the National Development and Reform Commission; it was selected as a major cutting-edge original technological achievement transformation and industrialization project in Zhongguancun, and become a resident enterprise in the Exhibition center of Zhongguancun National Independent Innovation Demonstration Zone, it is a representative enterprise in the field of biomedicine in Zhongguancun for 40 years; undertake the 863 special project in the field of new materials of the Ministry of Science and Technology of the State "Twelfth Five-Year", a number of provincial and ministerial topics such as innovative varieties of the Beijing Municipal Science&Technology Commission, and the research results won the second prize of provincial scientific and technological progress.

Looking forward to the future, Biosis Healing will continue to focus on the development of regenerative medicine, and is committed to improving the quality of life of the people, promoting innovation in the biomedical industry and localization of high-end medical devices, minimizing medical costs, and making unremitting efforts to gradually realize the substitution of imported medical devices.

Sincerely look forward to the excellent PhD student at home and abroad to engage in postdoctoral research at Biosis Healing! Work together to contribute to "Healthy China Going to the World"!




Friendship Links:

百度一下   |   京东   |  

版权所有®2019BIOSISHEALING